Atlas Trials

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Clinical trial NCT05154097 · UNKNOWN

Trial details

NCT number
NCT05154097
Sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Status
UNKNOWN
Study type
OBSERVATIONAL
Measles Vaccine
Start date
2022-01-04
Primary completion
2022-04-18
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.